A fair approach to discounting future effects: taking a societal perspective
- PMID: 10947546
- DOI: 10.1177/135581960000500210
A fair approach to discounting future effects: taking a societal perspective
Abstract
It is usually recommended that future costs and health effects are discounted at the same rate, usually 5%. In this paper it is argued that, from a societal perspective, this approach may be inappropriate for health effects. Instead of basing the discount rate for health effects on that for costs, it should be based on the real change in the (societal) valuation of health effects over time. Such valuation may change because of increasing life-expectancy and diminishing marginal utility of additional health effects over time.
Similar articles
-
Societal discounting of health effects in cost-effectiveness analyses: the influence of life expectancy.Pharmacoeconomics. 2005;23(8):791-802. doi: 10.2165/00019053-200523080-00005. Pharmacoeconomics. 2005. PMID: 16097841
-
A normative perspective on discounting health outcomes.J Health Serv Res Policy. 2013 Jul;18(3):186-9. doi: 10.1177/1355819613485671. Epub 2013 Jun 4. J Health Serv Res Policy. 2013. PMID: 23760622
-
NICE's selective application of differential discounting: ambiguous, inconsistent, and unjustified.Value Health. 2014 Jul;17(5):493-6. doi: 10.1016/j.jval.2013.02.014. Epub 2013 May 15. Value Health. 2014. PMID: 25128041
-
Discounting in the economic evaluation of health care interventions.Med Care. 1993 May;31(5):403-18. doi: 10.1097/00005650-199305000-00003. Med Care. 1993. PMID: 8501989 Review.
-
How to measure the cost-effectiveness of periodontal treatments.Periodontol 2000. 2012 Oct;60(1):138-46. doi: 10.1111/j.1600-0757.2011.00406.x. Periodontol 2000. 2012. PMID: 22909111 Review.
Cited by
-
Cost effectiveness analysis of neonatal extracorporeal membrane oxygenation based on four year results from the UK Collaborative ECMO Trial.Arch Dis Child Fetal Neonatal Ed. 2004 May;89(3):F263-8. doi: 10.1136/adc.2002.025635. Arch Dis Child Fetal Neonatal Ed. 2004. PMID: 15102733 Free PMC article. Clinical Trial.
-
Need for differential discounting of costs and health effects in cost effectiveness analyses.BMJ. 2005 Aug 20;331(7514):446-8. doi: 10.1136/bmj.331.7514.446. BMJ. 2005. PMID: 16110075 Free PMC article.
-
Towards a social discount rate for the economic evaluation of health technologies in Germany: an exploratory analysis.Eur J Health Econ. 2012 Apr;13(2):127-44. doi: 10.1007/s10198-010-0292-9. Epub 2010 Dec 19. Eur J Health Econ. 2012. PMID: 21170731
-
Value of Information Analysis Applied to the Economic Evaluation of Interventions Aimed at Reducing Juvenile Delinquency: An Illustration.PLoS One. 2015 Jul 6;10(7):e0131255. doi: 10.1371/journal.pone.0131255. eCollection 2015. PLoS One. 2015. PMID: 26146831 Free PMC article.
-
Cost effectiveness of treatments for amyotrophic lateral sclerosis: a review of the literature.Pharmacoeconomics. 2002;20(6):367-87. doi: 10.2165/00019053-200220060-00002. Pharmacoeconomics. 2002. PMID: 12052096 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical